Coronavirus (COVID-19) and related research reagents available from the NIBSC

Centre for AIDS Reagents

The NIBSC is home to the Centre for AIDS Reagents (CFAR) repository. Established in 1989 with grant funding from  WHO and MRC, CFAR is Europe’s only dedicated HIV reagent facility providing affordable access to over 6,500 reagents.

This valuable and irreplaceable collection is available to HIV/AIDS researchers worldwide to support the development of vaccines and treatments. CFAR also acts as a Legacy Repository for many research tools and materials created with short term funding to scientists from all over the world.

We provide the following types of reagents and services:

•         Large single batches of reagents for collaborative experiments
•         Historic HIV virus strains as well as novel HIV subtypes from recent infections
•         A bespoke reagent production and sourcing service
•         A Safe banking facility for valuable research materials

The repository is ISO9001 accredited for receipt, storage and dispatch of reagents.

We are actively working towards an expansion of the CFAR repository to ensure we can continue to support HIV research and also offer our infrastructure model to provide the same benefits in support of other research challenges. A selection of reagents for research into Malaria, Tuberculosis, Hepatitis B,Hepatitis C and SARS CoV 2 are available on request.